Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 2, facilitated glucose transporter member 7 (SLC2A7 or GLUT7) is a membrane protein in humans that functions as a facilitated transporter for glucose and fructose[1][2][4][5]. It is part of the GLUT (facilitated glucose transporter) family, characterized by 12 transmembrane helices and a conserved structural motif[2][3]. SLC2A7/GLUT7 is predominantly expressed in the small intestine, colon, testis, and prostate, with a key functional localization at the enterocyte brush-border membrane in the intestine[1][4]. It has high-affinity for both glucose and fructose transport (Km ≈ 0.3 mM for glucose; IC50 ≈ 0.06 mM for fructose), does not transport galactose, and is not inhibited by phloretin or cytochalasin B[1]. To date, no drugs are known to selectively target SLC2A7, and its precise role in human disease is not fully elucidated[5]. Its unique substrate profile and expression pattern suggest physiological importance in intestinal monosaccharide handling[1][4].
Not applicable (no drugs known to directly modulate this transporter)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 2, facilitated glucose transporter member 7 (SLC2A7 (also known as GLUT7)).